arXiv subjects

Lawson Ung

Publications and source records attributed to Lawson Ung.

5 recordsLinked to original sources

arXiv2026

Using the target trial framework for combining information: external comparator analyses and other applications

We describe how the target trial framework can be used to plan and report analyses that attempt to answer causal questions by combining information from multiple, diverse sources. Such analyses may involve comparisons of treatments evaluated in different populations, for example when an index trial is combined with other data sources in external comparator analyses, or when extending causal inferences from a randomized trial to a new target population in generalizability and transportability analyses. When planning such analyses, the specification of the target trial supports the explicit definition of the target population with an associated sampling model. We propose this as an additional component for the target trial framework, especially relevant for analyses that combine information, because it influences the choice of eligibility criteria, the specification of the causal model, the choice of causal contrasts, and reasoning about identification strategies. Furthermore, the framework encourages careful mapping of data elements from multiple data sources to a single target trial. This mapping process can highlight potentially irreconcilable misalignments between data sources with respect to specific components of the framework -- for example, in the definitions of eligibility criteria, treatment assignment, and treatment receipt. Such misalignments can arise when attempts to specify a target trial that aligns with a specific data source introduce or worsen misalignments with other proposed data sources. The extent of such misalignments may warrant switching to other data sources, or prospectively obtaining data, to emulate the proposed target trial. We conclude that the target trial framework promotes transparent discussion about the design of and assumptions made in analyses that answer causal questions by combining information from diverse sources.

stat.ME↗

arXiv2026

Identification strategies for combining an experimental study with external data

There is increasing interest in combining information from experimental studies, including randomized and single-group trials, with information from external experimental or observational data sources. Such efforts are usually motivated by the desire to compare treatments evaluated in different studies -- for instance, by constructing external comparator groups for some index study -- or to estimate treatment effects with greater precision. Proposals to combine experimental studies with external data were made at least as early as the 1970s, but in recent years have come under increasing consideration within clinical practice and by regulatory agencies involved in drug and device evaluation, particularly with the increasing availability of trial and observational data. In this paper, we describe basic study templates that combine information from experimental studies with external data, and use the potential (counterfactual) outcomes framework to elaborate identification strategies for potential outcome means and average treatment effects. We argue that these identification strategies inherit ideas relevant to the study of causation in single-source studies and the related literature on combining information (e.g., generalizability and transportability methods), but merit consideration as a separate class of causal problems because they differ in terms of their scientific motivations, definitions of the target population, sampling, data structures, and identifiability conditions. In formalizing identification strategies for the analyses described herein, we hope to provide a conceptual foundation to support the systematic use and evaluation of such efforts.

stat.ME↗

arXiv2026

Constructing external comparator groups via transportability in mean or in effect measure

Learning about causal effects in target populations and their subsets may be facilitated by combining information from multiple sources. One major class of study designs that combine information involves appending an index study with data from an external comparator, which may facilitate head-to-head comparisons of treatments initially studied in different populations. We delineate external comparator analyses under two distinct, but related, identification strategies. The first strategy relies on exchangeability (transportability) of potential outcome means, which uses information only on the treatments that are to be compared. The second strategy relies on transportability in effect measure, requiring additional use of information on a third treatment common to the populations that have been combined. In a time-fixed setting with a point treatment and non-failure time outcome, we examine identification and estimation under a basic setup where information from an index trial is combined with a second, and external to the index trial, data source. We propose estimators for identifying observed data functionals, with a particular focus on semiparametric efficient augmented weighting estimators that incorporate models for the probability of trial participation, the probability of treatment, and conditional outcome means. We derive the asymptotic properties of these augmented weighting estimators -- including robustness to model misspecification and slower rates of convergence for some nuisance function models -- and use simulation to compare their finite sample performance to estimators based only on outcome modeling or weighting. Last, we provide a practical demonstration of the proposed methods by combining the ACCEPT and PHOENIX 1 randomized trials to evaluate the effect of various biologic agents on plaque psoriasis, a chronic inflammatory disorder.

stat.ME↗

arXiv2025

The role of assignment in defining and identifying causal effects in randomized trials

In randomized trials, the per-protocol effect, that is, the effect of being assigned a treatment strategy and receiving treatment according to the assigned strategy, is sometimes thought to reflect the effect of the treatment strategy itself, without intervention on assignment. Here, we argue by example that this is not necessarily the case. We examine a causal structure for a randomized trial where these two causal estimands -- the per-protocol effect and the effect of the treatment strategy -- are not equal, and where their corresponding identifying observed data functionals are not the same, but both require information on assignment for identification. Our example highlights the conceptual difference between the per-protocol effect and the effect of the treatment strategy, the conditions under which these causal estimands are equal, and suggests that in some cases their identification requires information on assignment, even when assignment is randomized. Furthermore, both per-protocol effects and effects of treatment may be unidentifiable without information on treatment assignment, unless one makes additional assumptions -- informally, that assignment does not affect the outcome except through treatment (i.e., an exclusion-restriction assumption), and that assignment is not a confounder of the treatment-outcome association conditional on other variables in the analysis. Our analyses suggest a need to more clearly define the role of assignment when specifying causal effects of interest in randomized trials, which has implications for identification, analysis methods, and the interpretation of trial results.

stat.ME↗

arXiv2024

Generalizing and transporting causal inferences from randomized trials in the presence of trial engagement effects

Trial engagement effects are effects of trial participation on the outcome that are not mediated by treatment assignment. Most work on extending (generalizing or transporting) causal inferences from a randomized trial to a target population has, explicitly or implicitly, assumed that trial engagement effects are absent, allowing evidence about the effects of the treatments examined in trials to be applied to non-experimental settings. Here, we define novel causal estimands and present identification results for generalizability and transportability analyses in the presence of trial engagement effects. Our approach allows for trial engagement effects under assumptions of no causal interaction between trial participation and treatment assignment on the absolute or relative scales. We show that under these assumptions, even in the presence of trial engagement effects, the trial data can be combined with covariate data from the target population to identify average treatment effects in the context of usual care as implemented in the target population (i.e., outside the experimental setting). The identifying observed data functionals under these no-interaction assumptions are the same as those obtained under the stronger identifiability conditions that have been invoked in prior work. Therefore, our results suggest a new interpretation for previously proposed generalizability and transportability estimators; this interpretation may be useful in analyses under causal structures where background knowledge suggests that trial engagement effects are present but interactions between trial participation and treatment are negligible.

stat.ME↗